CTIS2022-500109-41-00招募中1 期
OPTIMISE: Optimized Immunosuppression for Corneal Transplantation: a multi-centre randomized controlled clinical trial
niversity Hospital Maastricht0 个研究点目标入组 442 人开始时间: 2022年3月24日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 442
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Patients aged 21 years or older registered on the NOTR as candidates for DMEK corneal transplantation
排除标准
- •Inability to complete follow up or comply with study procedures, Previous corneal graft in the study eye, Known sensitivity or contraindication to the ingredients in the study medications, History of uveitis or herpetic keratitis, Human Leukocyte Antigen (HLA) typed allograft, Pregnancy (current and planned) or lactation, Use of other local or systemic immunosuppressive drugs
研究者
相似试验
招募中
4 期
The OPTIMISE StudyPseudophakic Bullous KeratopathyFuchs' Endothelial DystrophyIntraocular PressureNCT05716945Maastricht University Medical Center342
招募中
不适用
The new guidline of corneal transplantation based on the inflammatory Cytokines in the Tears.eyes that have candidate for the corneal transplantationJPRN-UMIN000015070Tokyo Dental College45
Unknown
不适用
Clinical Study on the Treatment of Mixed Component Cornea for High Risk KeratoplastyCorneal TransplantationNCT04490902Zhongshan Ophthalmic Center, Sun Yat-sen University80
进行中（未招募）
Unknown
Assessing corneal integrity in healthy eyes and eyes after laser refractive surgeryPost-LASIKCorneal nerve functionEye - Diseases / disorders of the eyeEye - Normal eye development and functionACTRN12623000830695The University of Melbourne29
已完成
不适用
Efficacy and Safety of minimally invasive corneal cross linking: KeraVio studyKeratoconus and other corneal ectasiaJPRN-UMIN000031829Minamiaoyama Eye Clinic20